These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 9307889)

  • 1. Gangliosides and autoimmune diabetes.
    Misasi R; Dionisi S; Farilla L; Carabba B; Lenti L; Di Mario U; Dotta F
    Diabetes Metab Rev; 1997 Sep; 13(3):163-79. PubMed ID: 9307889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target antigens in autoimmune diabetes: pancreatic gangliosides.
    Dionisi S; Dotta F; Diaz-Horta O; Carabba B; Viglietta V; Di Mario U
    Ann Ist Super Sanita; 1997; 33(3):433-5. PubMed ID: 9542277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes.
    Dotta F; Gianani R; Previti M; Lenti L; Dionisi S; D'Erme M; Eisenbarth GS; Di Mario U
    Diabetes; 1996 Sep; 45(9):1193-6. PubMed ID: 8772721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat pancreatic ganglioside expression: differences between a model of autoimmune islet B cell destruction and a normal strain.
    Dotta F; Tiberti C; Previti M; Anastasi E; Andreani D; Lenti L; Pontieri GM; Gianani R; Appel MC; Eisenbarth GS
    Clin Immunol Immunopathol; 1993 Feb; 66(2):143-9. PubMed ID: 8453786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GM2-1 ganglioside islet autoantigen in insulin-dependent diabetes mellitus is expressed in secretory granules and is not beta-cell specific.
    Dotta F; Previti M; Neerman-Arbez M; Dionisi S; Cucinotta D; Lenti L; Di Mario U; Halban PA
    Endocrinology; 1998 Jan; 139(1):316-9. PubMed ID: 9421429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic islet ganglioside expression in nonobese diabetic mice: comparison with C57BL/10 mice and changes after autoimmune beta-cell destruction.
    Dotta F; Peterson LB; Previti M; Metzger J; Tiberti C; Anastasi E; Zoppitelli P; Wicker LS; Di Mario U
    Endocrinology; 1992 Jan; 130(1):37-42. PubMed ID: 1727711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-ganglioside antibodies in new onset type 1 diabetic patients and high risk subjects.
    Tiberti C; Dotta F; Anastasi E; Torresi P; Multari G; Vecci E; Andreani D; Di Mario U
    Autoimmunity; 1995; 22(1):43-8. PubMed ID: 8882421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-cell markers and autoantigen expression by a human insulinoma cell line: similarities to native beta cells.
    Cavallo MG; Dotta F; Monetini L; Dionisi S; Previti M; Valente L; Toto A; Di Mario U; Pozzilli P
    J Endocrinol; 1996 Jul; 150(1):113-20. PubMed ID: 8708552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to the GM2-1 islet ganglioside and to GAD-65 at type 1 diabetes onset.
    Dotta F; Falorni A; Tiberti C; Dionisi S; Anastasi E; Torresi P; Lernmark A; Di Mario U
    J Autoimmun; 1997 Dec; 10(6):585-8. PubMed ID: 9451598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against ganglioside GT3 in the sera of patients with type I diabetes mellitus.
    Gillard BK; Thomas JW; Nell LJ; Marcus DM
    J Immunol; 1989 Jun; 142(11):3826-32. PubMed ID: 2654294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GM2-1 pancreatic islet ganglioside: identification and characterization of a novel islet-specific molecule.
    Dotta F; Previti M; Lenti L; Dionisi S; Casetta B; D'Erme M; Eisenbarth GS; Di Mario U
    Diabetologia; 1995 Sep; 38(9):1117-21. PubMed ID: 8591828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic determinants in type 1 diabetes mellitus. Review article.
    Dotta F; Di Mario U
    APMIS; 1996 Nov; 104(11):769-74. PubMed ID: 8982239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction.
    Dotta F; Eisenbarth GS
    Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 2):S85-95. PubMed ID: 2642771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
    Durinovic-Belló I
    Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-ganglioside autoantibodies in type 1 diabetes.
    Lucchetta M; Rudilosso S; Costa S; Bruttomesso D; Ruggero S; Toffanin E; Faggian D; Plebani M; Battistin L; Alaedini A; Briani C
    Muscle Nerve; 2010 Jan; 41(1):50-3. PubMed ID: 19768773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of organ-specific autoantibodies and celiac disease--associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects.
    Jaeger C; Hatziagelaki E; Petzoldt R; Bretzel RG
    Diabetes Care; 2001 Jan; 24(1):27-32. PubMed ID: 11194235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A distinct ganglioside composition of rat pancreatic islets.
    Saito M; Sugiyama K
    Arch Biochem Biophys; 2000 Apr; 376(2):371-6. PubMed ID: 10775425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance.
    Baekkeskov S
    Mol Biol Med; 1986 Apr; 3(2):137-42. PubMed ID: 3526081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus.
    Togun RA; Resetkova E; Kawai K; Enomoto T; Volpé R
    Clin Immunol Immunopathol; 1997 Mar; 82(3):243-9. PubMed ID: 9073547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel considerations on the antibody/autoantigen system in type I (insulin-dependent) diabetes mellitus.
    Bottazzo GF; Genovese S; Bosi E; Dean BM; Christie MR; Bonifacio E
    Ann Med; 1991 Oct; 23(4):453-61. PubMed ID: 1930942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.